Clincial Trials Confirm Accuracy of SpermCheck Vasectomy

Filed in archive Diagnostics, Methodologies and Instrumentation on December 1, 2008

In a clinical trial involving 144 post-vasectomy semen samples, researchers have confirmed the accuracy and reliability of SpermCheck Vasectomy, the first FDA approved at-home immunodiagnostic test for detecting low concentrations of sperm.

The test achieved an accuracy rate of 96 percent in identifying whether sperm counts were greater or less than a threshold of 250,000 sperm per ml - a level associated with little or no risk of causing pregnancy. SpermCheck proved to be 100 percent accurate in identifying whether sperm counts were greater or less than 384,000 sperm per ml.

SpermCheck Vasectomy will be available for sale in March 2009. Click here for more details.